Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLONAZEPAM for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 22 adverse event reports in the FDA FAERS database where CLONAZEPAM was used for Maternal exposure timing unspecified.

Most Reported Side Effects for CLONAZEPAM

Side Effect Reports % Deaths Hosp.
Drug ineffective 5,088 12.9% 114 1,046
Toxicity to various agents 4,028 10.2% 2,868 1,396
Completed suicide 3,320 8.4% 3,302 915
Drug abuse 3,287 8.3% 1,271 1,202
Off label use 2,590 6.6% 214 1,056
Anxiety 2,376 6.0% 53 746
Somnolence 2,260 5.7% 104 824
Dyspnoea 1,987 5.0% 66 658
Depression 1,838 4.7% 152 558
Insomnia 1,836 4.7% 43 467
Fatigue 1,831 4.6% 56 519
Vomiting 1,735 4.4% 47 648
Headache 1,702 4.3% 28 603
Malaise 1,651 4.2% 29 449
Pneumonia 1,580 4.0% 70 632

Other Indications for CLONAZEPAM

Product used for unknown indication (18,548) Anxiety (3,716) Epilepsy (1,164) Insomnia (1,003) Seizure (919) Depression (863) Bipolar disorder (665) Panic attack (658) Panic disorder (598) Sleep disorder (580)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

CLONAZEPAM Full Profile All Maternal exposure timing unspecified Drugs CLONAZEPAM Demographics CLONAZEPAM Timeline